GURU.Markets stock price, segment price, and overall market index valuation
The company's share price AKAN
Akanda is an international company that cultivates and sells medical cannabis. Its share price reflects the complex and fragmented global cannabis market, including regulatory barriers and intense competition.
Share prices of companies in the market segment - Narco farm
Akanda Corp. is an international medical cannabis company that grows its raw materials in Africa and supplies them to European markets. We've classified it as a "Narco-Pharma" company. The chart below shows the dynamics of this sector of the global cannabis industry.
Broad Market Index - GURU.Markets
Akanda is an international company engaged in the cultivation, production, and distribution of medical cannabis. It is a component of the GURU.Markets index. The chart below shows the market. See how this company's stock compares to the cannabis industry.
Change in the price of a company, segment, and market as a whole per day
AKAN - Daily change in the company's share price AKAN
The daily fluctuations of Akanda Corp., a cannabis company, reflect the sector's high volatility. The metric demonstrates sensitivity to regulatory developments in Europe and product prices.
Daily change in the price of a set of shares in a market segment - Narco farm
Akanda was an international medical cannabis company. This sector is characterized by high volatility due to changing regulations and intense competition. The chart below shows average fluctuations in the cannabis industry, reflecting regulatory risks and investor sentiment.
Daily change in the price of a broad market stock, index - GURU.Markets
Akanda is an international cannabis company. Its shares reflect both the industry's rapid growth and the high regulatory risks in various countries. The dynamics of this sector add a unique and volatile element to the overall market landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization AKAN
Akanda Corp.'s year-over-year performance tells the story of its attempt to build a global cannabis business with African roots. Its market cap change over the past 12 months reflects its struggle to survive in a challenging market, as well as its successes (and failures) in establishing a supply chain from cultivation in Lesotho to sales in European medical markets.
Annual dynamics of market capitalization of the market segment - Narco farm
Akanda, as a cannabis company, is demonstrating momentum closely tied to progress in legalization and product prices. Its performance relative to the sector will demonstrate the success of its strategy to build brands and enter new markets in this highly volatile industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Akanda, an international cannabis company, reflects the complexities and opportunities of the global market through its dynamics. Its performance, compared to the market, is a story of navigating the patchwork of laws across multiple countries and building an efficient supply chain in an unstable industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization AKAN
Akanda is an international medical cannabis company. Its monthly performance reflects the progress of its operations in Europe and Africa, as well as the complex and evolving regulatory trends in the global cannabis industry.
Monthly dynamics of market capitalization of the market segment - Narco farm
The international medical cannabis market is still in its infancy and fraught with regulatory barriers. The sector's dynamics, shown in the chart, reflect this uncertainty. In this environment, companies like Akanda are attempting to build their businesses in Europe.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Akanda, an international medical cannabis company, operates in a volatile and evolving market. Its shares are driven by news of legalization and industry consolidation, rather than by general economic trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization AKAN
Akanda, a medical cannabis company, shares reflect the state of the volatile industry in Europe. Its stock price reacts to legislative changes in various countries, supply news, and price competition. The chart below shows how short-term regulatory and market events affect the valuation of this international player.
Weekly dynamics of market capitalization of the market segment - Narco farm
Akanda operates in the medical cannabis industry in Europe. This market has enormous growth potential, but is highly dependent on legislative changes in each individual country. The chart below shows how much the company's stock price reflects these regulatory risks and expectations, rather than general trends in the pharmaceutical sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Akanda operates in the volatile cannabis industry. This chart compares its weekly performance to the broader market. It clearly shows how its shares are driven by legalization news and sector-specific events, often ignoring the overall sentiment of the S&P 500.
Market capitalization of the company, segment and market as a whole
AKAN - Market capitalization of the company AKAN
Akanda Corp.'s price chart reflects the complexities of the international medical cannabis market. The company's market cap, which has assets in Africa and Europe, depends on regulatory changes and its ability to establish profitable sales. Its dynamics illustrate how investors view this risky and unsettled industry.
AKAN - Share of the company's market capitalization AKAN within the market segment - Narco farm
Akanda's market share in the cannabis sector reflects its international ambitions. With production facilities in Africa and distribution in Europe, its market weight is a bet on its potential to become a major player in the global medical cannabis supply chain.
Market capitalization of the market segment - Narco farm
Take a look at the chart: it's the total market capitalization of the cannabis industry. Akanda, with its focus on international markets, is part of this volatile ecosystem. The dynamics on the chart reflect regulatory changes, profitability challenges, and the intense competition in this emerging sector.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart depicts the market value of the international medical cannabis business. Akanda's market capitalization is a bet on its production facilities in Africa and Europe. The line shows how the company is attempting to gain market share in the emerging and highly competitive global industry.
Book value capitalization of the company, segment and market as a whole
AKAN - Book value capitalization of the company AKAN
This chart illustrates the assets of Akanda Corp., an international medical cannabis company. The line represents the combined value of its greenhouses in Portugal and Lesotho, as well as its distribution network. The trend shows how the company is investing in its infrastructure to enter European markets.
AKAN - Share of the company's book capitalization AKAN within the market segment - Narco farm
Akanda's tangible assets include its medical cannabis cultivation and processing facilities in Portugal and Lesotho. The chart shows the company's share of this international agricultural and production infrastructure, targeting European and other markets.
Market segment balance sheet capitalization - Narco farm
Unlike traditional pharmaceuticals, Akanda, as a cannabis producer, is building its capital-intensive infrastructure from scratch. Its business requires greenhouses and processing facilities, which are the foundation of its "seed-to-sale" model.
Book value of all companies included in the broad market index - GURU.Markets
Akanda is an international company engaged in the cultivation and processing of medical cannabis. Its assets include plantations and production facilities in countries with favorable climates and legal regulations. The chart below illustrates the company's physical scale in the nascent global cannabis industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - AKAN
Akanda is an international company engaged in the cultivation and sale of medical cannabis. Its market capitalization reflects the value of its licenses, production capacity, and its expectations for the growth of the global cannabis market.
Market to book capitalization ratio in a market segment - Narco farm
Akanda Corp. is an international company engaged in the cultivation and processing of medical cannabis. Its valuation depends on legalization, product prices, and operational efficiency. This chart shows how the market values its assets (greenhouses, licenses) in this volatile industry.
Market to book capitalization ratio for the market as a whole
Akanda Corp is an international company engaged in the cultivation and processing of medical cannabis. This chart shows how investors value its licenses, production facilities in various countries, and growth potential in the global legal cannabis market. The valuation is highly dependent on regulatory changes in the industry.
Debts of the company, segment and market as a whole
AKAN - Company debts AKAN
Akanda, a company that cultivates and sells medical cannabis, manages its finances in a challenging and evolving industry. This chart shows how the company is investing in its production facilities in Europe and establishing distribution channels while facing regulatory barriers and intense competition.
Market segment debts - Narco farm
Akanda is an international medical cannabis company with assets in Africa and Europe. The cannabis industry is capital-intensive and faces regulatory challenges. This chart shows how the company's debt load reflects its struggle to create a sustainable business model, develop production capacity, and achieve profitability in this new and volatile market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio AKAN
Elevai Labs operates in the cosmeceutical niche, developing exosome-based skincare products. This innovative approach requires investment in R&D and marketing. This chart shows how the company is funding its growth, betting that its cutting-edge science will resonate with consumers in the competitive beauty market.
Market segment debt to market segment book capitalization - Narco farm
Akanda is an international company engaged in the cultivation, production, and distribution of medical cannabis. This chart compares its debt to the overall market capitalization of the entire sector. It illustrates how a company operating in a young and highly regulated industry is financing its production capacity and global expansion.
Debt to book value of all companies in the market
Akanda Corp. aims to become a global player in the medical cannabis market, with operations in Europe and Africa. This is a young industry with evolving regulations and high capital expenditures. This graph of total market debt shows Akanda's risk appetite, which is important for assessing Akanda's ability to attract financing to build its international network.
P/E of the company, segment and market as a whole
P/E - AKAN
This chart shows the valuation of Akanda, a company operating in the medical cannabis market. The P/E for such a company (if positive) would reflect its ability to be profitable in an environment of high competition, oversupply, and complex regulations in various countries.
P/E of the market segment - Narco farm
Akanda is an international company engaged in the cultivation and processing of medical cannabis. Its main production facilities are located in the Kingdom of Lesotho, ensuring low production costs. This chart reflects the overall assessment of the entire cannabis industry, providing insight into how the market views players focusing on international production.
P/E of the market as a whole
Akanda is an international medical cannabis company with operations in Lesotho and Portugal. The company aims to supply high-quality cannabis to European markets. This chart, showing overall sentiment, provides an overview of investor sentiment for companies in the global cannabis industry.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company AKAN
Akanda is an international company engaged in the cultivation and processing of medical cannabis. This chart reflects analysts' expectations for future revenue, which depend on the legalization of cannabis in various countries, the company's ability to establish production and distribution, and raw material prices.
%20P%2FE%20AKAN&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-AKAN&v=1772661337386 "Chart of the company's future (projected) P/E AKAN")
Future (projected) P/E of the market segment - Narco farm
Akanda is an international medical cannabis company seeking to expand into European markets. This chart shows how the market views its chances of success in the complex and highly regulated sector. It compares expectations for Akanda with other cannabis producers competing for profitability and market share.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772661337395 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
Akanda is an international company engaged in the cultivation and processing of medical cannabis. The development of this market is highly dependent on regulatory changes around the world and the investment climate. This chart, reflecting general sentiment, demonstrates the investor appetite for risk, which is necessary to finance companies in such a young and volatile industry.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772661337411 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit AKAN
Akanda Corp. is an international company engaged in the cultivation and processing of medical cannabis. Its financial performance depends on production capacity, cannabis prices, and access to legal markets in Europe and other regions. This chart shows the company's path in the evolving but regulatoryly complex global cannabis industry.
Profit of companies in the market segment - Narco farm
Akanda Corp. cultivates and processes medical cannabis for the international market. This graph, showing overall profitability in the sector, reflects the high volatility and growth potential of the cannabis industry. Akanda's ability to establish efficient production and logistics for export directly impacts its financial performance and the industry as a whole.
Overall market profit
Akanda is an international medical cannabis company with operations in Europe and Africa. Its growth depends on the legalization of cannabis in various countries and the ability to build an efficient supply chain. The company is betting on the emergence of a new global market, whose dynamics are driven by regulatory changes.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company AKAN
Akanda is an international medical cannabis company with operations in Africa and Europe. The future revenue projections presented here are contingent on cannabis legalization in key markets, obtaining licenses, and ramping up production. Analysts assess the company's potential in the emerging European market.
%20profit%20of%20the%20company%20AKAN&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-AKAN&v=1772661337479 "Graph of future (projected) profit of the company AKAN")
Future (predicted) profit of companies in the market segment - Narco farm
Akanda is an international company engaged in the cultivation, production, and distribution of medical cannabis. This chart reflects profit forecasts for the entire legal cannabis industry. It shows analysts' expectations for this rapidly growing market, which still faces regulatory barriers and high competition.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772661337490 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
Akanda cultivates and processes medical cannabis in Europe. The market is still in its infancy and is highly dependent on regulatory changes. This chart, which reflects overall economic sentiment, is important, as during periods of growth, consumers and healthcare systems may be more receptive to the adoption and use of new therapies, including medical cannabis.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772661337493 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - AKAN
Akanda is an international medical cannabis company with operations in Africa and Europe. This chart, comparing market capitalization to revenue, reflects investor sentiment regarding the global cannabis market. It demonstrates the company's "seed-to-patient" business model and its ability to compete in the nascent European market.
P/S market segment - Narco farm
Akanda Corp. is an international company engaged in the cultivation, production, and distribution of medical cannabis. The company strives to supply high-quality products to European and other markets. This chart reflects how investors value revenue in the growing cannabis industry, demonstrating the level of confidence in Akanda's business model and international strategy.
P/S of the market as a whole
Akanda Corp. is an international company engaged in the cultivation and processing of medical cannabis in Europe and Africa. Its success depends on the legalization and development of the medical cannabis market. This chart helps assess how investors perceive revenue in the volatile and evolving cannabis industry compared to the overall market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company AKAN
Akanda is an international company engaged in the cultivation and distribution of medical cannabis. This chart shows how the market values the company based on its projected future sales. It reflects investor expectations for cannabis legalization in Europe and Akanda's ability to capture a significant share of this emerging market.
%20P%2FS%20AKAN&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-AKAN&v=1772661337565 "The graph of the company's future (projected) P/S AKAN")
Future (projected) P/S of the market segment - Narco farm
Akanda is an international company engaged in the cultivation and processing of medical cannabis, with operations in Europe and Africa. The chart displays the average estimated future sales for the cannabis sector. It provides an insight into the market's perception of Akanda's prospects amid the evolving European medical cannabis market and the highly competitive industry.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772661337574 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
Akanda (AKAN) is an international company engaged in the cultivation and sale of medical cannabis. Their growth is entirely dependent on legislative changes (legalization) in various countries and the ability to establish distribution. This chart of general economic expectations does not reflect the specific drivers of this emerging industry.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772661337600 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales AKAN
Akanda's revenue is generated in the emerging medical cannabis market. The company cultivates, produces, and distributes cannabis-based products for medical purposes. Growth will depend on obtaining licenses, expanding production capacity, and developing distribution channels in European and other legal markets.
Sales of companies in the market segment - Narco farm
Akanda Corp. is an international company engaged in the cultivation and processing of medical cannabis. As its revenue structure grows, it will reflect a shift in revenue from raw material sales to high-value-added finished products, reflecting its strategy of covering the entire supply chain.
Overall market sales
Akanda Corp. is an international company engaged in the cultivation and processing of medical cannabis. The company's growth depends on legalization, regulatory changes, and the acceptance of its products by the medical community. This chart, reflecting overall consumer spending, indirectly shows how the economic situation can influence the development of new markets, such as medical cannabis.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company AKAN
Akanda is an international medical cannabis company seeking to supply products to European markets. Its future revenue depends on obtaining licenses, ramping up production, and developing distribution channels. This chart reflects analysts' forecasts for the legalization and growth of the medical cannabis market in Europe.
%20sales%20of%20the%20company%20AKAN&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-AKAN&v=1772661337684 "Schedule of future (projected) sales of the company AKAN")
Future (projected) sales of companies in the market segment - Narco farm
Akanda Corp. is an international company engaged in the cultivation, production, and distribution of medical cannabis. This chart shows the forecast for the entire cannabis sector. Its dynamics are directly dependent on the pace of legalization in Europe and other regions, which determines market opportunities and Akanda's expansion strategy.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772661337695 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
This chart, reflecting market sentiment and regulatory trends, is important for Akanda. The company, which operates in the medical cannabis sector, is dependent on legalization and market development in Europe. Overall economic stability facilitates more informed and rapid policy decision-making in this emerging industry.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772661337775 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality AKAN
Akanda is an international medical cannabis company with operations in Europe and Africa. This chart illustrates the challenges and potential of the global cannabis market. Achieving profitability depends on obtaining licenses, efficient cultivation, establishing distribution channels, and regulatory changes in various countries.
Market segment marginality - Narco farm
Akanda is an international company engaged in the cultivation and processing of medical cannabis. Its profitability depends on production costs, legalization in new markets, and the ability to supply high-quality products. This chart shows profitability in related sectors, providing context for assessing the success of Akanda's business model in the global cannabis market.
Market marginality as a whole
Akanda cultivates and processes medical cannabis in Europe. The development of this new market is highly dependent on legislation and consumer demand. This trend, reflecting the overall economic situation, influences investment interest in the sector and consumers' ability to afford medical cannabis products, which are not always covered by insurance.
Employees in the company, segment and market as a whole
Number of employees in the company AKAN
Akanda Corp. cultivates and processes medical cannabis. This chart shows the size of the team working at its production facilities. This trend illustrates how the company is scaling its cultivation and processing operations to meet demand in emerging medical cannabis markets in Europe and other regions.
Share of the company's employees AKAN within the market segment - Narco farm
Akanda is an international company engaged in the cultivation and processing of medical cannabis, with assets in Africa and Europe. This chart shows the company's share of total employment in the legal cannabis industry. This reflects its global ambitions, production capacity, and strategy for creating a vertically integrated supply chain.
Number of employees in the market segment - Narco farm
Akanda Corp. is an international company engaged in the cultivation, production, and distribution of medical cannabis. This chart, reflecting employment in the legal cannabis sector, is crucial. The growing number of agronomists, technologists, and quality specialists in this young industry testifies to its rapid growth, legalization, and improved production standards.
Number of employees in the market as a whole
Akanda cultivates and processes medical cannabis. The legalization and growth of this market depend on a stable social and economic environment. This total employment chart reflects economic health, which allows governments to create a regulatory framework and consumers to spend money on new types of therapeutic and recreational products.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company AKAN (AKAN)
Akanda Corp. is an international company engaged in the cultivation and processing of medical cannabis. This is a capital-intensive agribusiness, requiring expensive greenhouses and licenses. At the same time, it is a rapidly growing market. This metric reflects how the market values their assets (land, greenhouses) and licenses per employee engaged in cultivation and management.
%20of%20the%20company%20AKAN%20(AKAN)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-AKAN-AKAN&v=1772661337854 "Chart of market capitalization per employee (in thousands of dollars) of the company AKAN (AKAN)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Akanda cultivates and processes medical cannabis. This sector combines agricultural and pharmaceutical standards, which can require a significant workforce. This metric allows investors to compare Akanda's operating model with its competitors and understand the market value generated by each employee.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772661337887 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
Akanda is an international company engaged in the cultivation and processing of medical cannabis. This business is both agricultural and pharmaceutical, requiring both plantation workers and laboratory specialists. This indicator reflects the market's assessment of the company's ability to effectively manage its operations in this new and rapidly growing industry.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772661337893 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company AKAN (AKAN)
Akanda is an international company in the medical cannabis industry with assets in Africa (Lesotho) and Europe. It's a complex, highly regulated, and capital-intensive agribusiness. This chart shows their struggle to achieve profitability: how much the company spends (negative profit) on each employee (agronomist, logistics) in an attempt to establish profitable production and exports.
%20Chart%20AKAN%20(AKAN)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-AKAN-AKAN&v=1772661337898 "Company Profit Per Employee (in thousands of dollars) Chart AKAN (AKAN)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Akanda cultivates and processes medical cannabis. This chart reflects the efficiency of the company's agricultural technologies and production processes. In this new and competitive industry, the ability to produce a high-quality product with low labor costs is a key success factor, directly impacting profitability per employee.
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772661337921 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
Akanda (AKAN) is an international medical cannabis company with operations in Lesotho (Africa) and Europe. It's an agribusiness, but with a strong regulatory and medical component. This metric reflects how efficiently a company in this emerging industry generates profits, taking into account personnel costs—from agronomists in Africa to lawyers in Europe.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772661337946 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee AKAN (AKAN)
Akanda Corp. cultivates and processes medical cannabis. This chart illustrates how the company operates in a developing and challenging market. Revenue per employee trends will reflect their ability to scale up production and find markets for their products.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-AKAN-AKAN&v=1772661337952 "Sales chart per company employee AKAN (AKAN)")
Sales per employee in the market segment - Narco farm
Akanda is an international medical cannabis company focused on the European and UK markets. It's a capital-intensive agribusiness with strict regulations. This chart shows how productive their production facilities (greenhouses) and sales team are. It reflects their ability to generate revenue in this nascent industry.
Sales per employee for the market as a whole
La-Z-Boy (LZB) is one of the most recognizable brands in the furniture industry, known for its recliner chairs. The company operates its own manufacturing facility and a network of retail stores. This chart reflects the balance between manufacturing and retail. In the furniture business, which requires production, logistics, and sales, an increase in this indicator indicates operational efficiency, factory automation, and brand strength.
Short shares by company, segment and market as a whole
Shares shorted by company AKAN (AKAN)
Akanda (AKAN) is an international cannabis company. The entire marijuana industry is in deep crisis due to oversupply, falling prices, and the lack of legalization. This chart shows the number of short positions. The bears are betting that AKAN, like many others, will fail to achieve profitability.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-AKAN-AKAN&v=1772661337969 "Short Shares Chart for the Company AKAN (AKAN)")
Shares shorted by market segment - Narco farm
Akanda (AKAN) is an international medical cannabis company with operations in Africa and Europe. The chart below shows the overall short position in the cannabis sector. It demonstrates how skeptical investors are of the global market, anticipating challenges with legalization and price pressure.
Shares shorted by the overall market
Akanda is an international medical cannabis company. The sector is highly speculative and suffers from a lack of capital. This chart measures overall fear. When the cannabis sector's problems are compounded by general market pessimism, investors completely lose their appetite for risk, selling off AKANDA shares, fearing their inability to achieve profitability.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator AKAN (AKAN)
This chart for Akanda is an indicator of the cannabis boom's "hangover." The company was attempting to build an international cannabis business (in Lesotho) and distribute it in Europe. The stock was "overheated" (above 70) due to the legalization hype. The failure of the business model, supply disruptions, and fierce competition sent the stock into "oversold" territory (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-AKAN-AKAN&v=1772661337997 "RSI 14 indicator chart for the company's stock AKAN (AKAN)")
RSI 14 Market Segment - Narco farm
Akanda is an international medical cannabis company. Their strategy is to grow cannabis in low-cost regions (Lesotho) for supply to European markets. This chart reflects the overall sentiment in the volatile cannabis sector. It helps assess whether the entire segment is overheated or oversold.
RSI 14 for the overall market
Akanda (AKAN) is an international company engaged in the cultivation and processing of medical cannabis. This sector is extremely sensitive to regulatory changes and overall risk appetite. This chart shows when the market is in a state of euphoria (readiness for speculation) or panic (risk aversion). For AKAN shares, the euphoric phase is more favorable for raising capital.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AKAN (AKAN)
Akanda is an international cannabis company. Its strategy is to grow medical cannabis in Africa (Lesotho) for export to European markets (Germany, UK). This chart shows the speculative average 12-month price target from analysts, based on their belief in this complex business model.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AKAN-AKAN&v=1772661338082 "A chart showing analyst consensus forecasts for the expected stock price. AKAN (AKAN)")
The difference between the consensus estimate and the actual stock price AKAN (AKAN)
Akanda is an international cannabis holding company attempting to build a business in the cultivation (in Africa) and distribution (in Europe) of medical cannabis. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their view of the complex and immature European market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AKAN-AKAN&v=1772661338084 "A chart showing the difference between the consensus forecast and the actual stock price. AKAN (AKAN)")
Analyst consensus forecast for stock prices by market segment - Narco farm
Akanda is a premium cannabis holding company. The company is attempting to grow medical marijuana in Africa (Lesotho) for export to the European market (Germany). This chart reflects analysts' general expectations for the entire "drug farm" sector. It shows whether experts believe in this "Afro-European" business model.
Analysts' consensus forecast for the overall market share price
Akanda is an international cannabis company attempting to build a supply chain from Africa (Lesotho) to Europe (Germany). This chart shows the overall risk appetite in the market. For AKANDA, which operates in a volatile sector dependent on legalization, overall market optimism (the rising chart) is critical for funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index AKAN
Akanda is a global cannabis player. Their specialty is growing low-cost medical cannabis (in Lesotho, Africa) and exporting it to the (slowly legalizing) European market (Germany, UK). This chart is a summary indicator of their African bet. It reflects their (loss-making) growth and their dependence on (very complex) logistics and (slow) legalization in the EU.
AKIMA Market Segment Index - Narco farm
Akanda is an international medical cannabis company. They focus on cultivating premium cannabis in Europe (Portugal) and Africa (Lesotho) for the European markets. This chart compares their composite index to the sector, showing how their global cannabis farming strategy compares to their competitors.
The AKIM Index for the overall market
Akanda is an international medical cannabis company with assets in the UK and Portugal. It aims to supply products to Europe. This chart, reflecting the market average, is just a backdrop. It helps put this volatile story in the regulated sector into perspective, given the overall macroeconomic trends.
